Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Emeline Tabouret

22PUBLICATIONS

124CO-AUTHORS

Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationships

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|Mar 09, 2026

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Cameron Crowell, Nikhil P Mankuzhy, Julie Bennett

|Oct 16, 2025

Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. <i>Cancers</i> 2020, <i>12</i>, 1935.

Emeline Tabouret, Herui Wang, Niranjana Amin

|Nov 22, 2024

European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection.

Felix Sahm, Luca Bertero, Sebastian Brandner

|Oct 21, 2024

Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.

Domique Figarella-Branger, Carole Colin, Karima Mokhtari

|Oct 02, 2024

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Sep 10, 2024

Brain tumoroids: Treatment prediction and drug development for brain tumors with fast, reproducible, and easy-to-use personalized models.

Aurélie Soubéran, Carine Jiguet-Jiglaire, Soline Toutain

Pageof 4

Frequent Collaborators

7 joint publications

Domique Figarella-Branger

3 joint publications

Ahmed Idbaïh

2 joint publications

Niranjana Amin

2 joint publications

Georges Noel

2 joint publications

François Devred

2 joint publications

Romain Appay

2 joint publications

Marc Barritault

2 joint publications

David Meyronet

2 joint publications

Franck Bielle

2 joint publications

Elizabeth Cohen-Jonathan Moyal

Frequent Collaborators

7 joint publications

Domique Figarella-Branger

3 joint publications

Ahmed Idbaïh

2 joint publications

Niranjana Amin

2 joint publications

Georges Noel

Top Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Published on : Mar 07, 2017

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

See more related videos

Top Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Published on : Mar 07, 2017

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

See more related videos